International prevalence of transthyretin amyloid cardiomyopathy in high-risk patients with heart failure and preserved or mildly reduced ejection fraction

Thumbnail Image
International_prevalence_of_transthyretin_amyloid_cardiomyopathy_in_high-risk_patients_with_heart_failure_and_preserved_or_mildly_reduced_ejection_fra.pdf (3.16 MB)
Identifiers
URI: https://hdl.handle.net/10641/7737
ISSN: 1350-6129
DOI: 10.1080/13506129.2024.2398446

Publication date

2024

Start date of the public exhibition period

End date of the public exhibition period

Authors

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Share
Export

Research Projects

Organizational Units

Journal Issue

Doctoral program

Description

Publisher Copyright: © The work of Sergi Yun, Giovanni Palladini, Lisa J. Anderson, Eve Cariou and Pablo Garcia-Pavia is © 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group The work of Ronnie Wang, Franca S. Angeli and Ben Ebede is © 2024 Pfizer Inc.

Keywords

Amyloidosis, N-terminal pro B-type natriuretic peptide, carpal tunnel syndrome, epidemiology, interventricular septal thickness, left ventricular ejection fraction, Internal Medicine, Journal Article, Multicenter Study, Clinical Trial, Yes, yes

Citation

Yun, S, Palladini, G, Anderson, L J, Cariou, E, Wang, R, Angeli, F S, Ebede, B & Garcia-Pavia, P 2024, 'International prevalence of transthyretin amyloid cardiomyopathy in high-risk patients with heart failure and preserved or mildly reduced ejection fraction', Amyloid, vol. 31, no. 4, pp. 291-301. https://doi.org/10.1080/13506129.2024.2398446

Collections

FACULTAD DE MEDICINA